FXYD5 and thyroid cancer: In these studies, its expression correlated with tumor size, distant metastasis, regional lymph node metastasis, and disease specific survival in thyroid cancer, which is similar to the findings in our current study with the exception of the negative association of dysadherin overexpression with tumor size and distant metastases.